Expression of DKK1 in both serum and tissue levels has been reported to be a biomarker in diagnosis and predicting survival and tumor recurrence in stomach cancer (Lee et al., 2012; Liu et al., 2016; Hong et al., 2018). Here, DKK1 is linked to gastric neoplasm.